- Home
- HKIT vs GCTK Comparison
HKIT vs GCTK Comparison
Compare HKIT & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | GCTK |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 3.0M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | HKIT | GCTK |
|---|---|---|
| Price | $0.53 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.2M | 504.5K |
| Earning Date | 04-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.03 | $0.09 |
| 52 Week High | $8.80 | $15.90 |
Technical Indicators
Market Signals| Indicator | HKIT | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 30.20 |
| Support Level | N/A | N/A |
| Resistance Level | $1.97 | $1.02 |
| Average True Range (ATR) | 0.67 | 0.09 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 3.73 | 23.42 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.